Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Change in Receivables (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Change in Receivables for 16 consecutive years, with -$12.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 44.8% year-over-year to -$12.4 million, compared with a TTM value of -$56.7 million through Dec 2025, up 55.8%, and an annual FY2025 reading of -$56.7 million, up 55.8% over the prior year.
  • Change in Receivables was -$12.4 million for Q4 2025 at Cross Country Healthcare, up from -$22.4 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $195.5 million in Q4 2021 and bottomed at -$138.6 million in Q2 2023.
  • Average Change in Receivables over 5 years is $1.8 million, with a median of -$10.1 million recorded in 2023.
  • The sharpest move saw Change in Receivables surged 9392.83% in 2022, then crashed 650.69% in 2025.
  • Year by year, Change in Receivables stood at $195.5 million in 2021, then tumbled by 86.59% to $26.2 million in 2022, then crashed by 230.42% to -$34.2 million in 2023, then skyrocketed by 34.31% to -$22.5 million in 2024, then soared by 44.8% to -$12.4 million in 2025.
  • Business Quant data shows Change in Receivables for CCRN at -$12.4 million in Q4 2025, -$22.4 million in Q3 2025, and -$18.3 million in Q2 2025.